Home > Insider Trading > Filing (0001140361-17-011947)

Filing Details

Accession Number:: 0001140361-17-011947
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-14 17:29:52
Reporting Period:: 2017-03-03

Filing Date:: 2017-03-14
Accepted Time:: 2017-03-14 17:29:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
934473	Genvec Inc	GNVC	Pharmaceutical Preparations (2834)	232705690

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304857	Mmcap International Inc. Spc	P.o. Box 259 George Town Financial Centre, 90 Fort St Grand Cayman E9 KY1-1104		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2017-03-03	1,300	$6.86	236,585	No	4	P	Direct
Common Shares	Acquisiton	2017-03-06	2,857	$6.74	239,442	No	4	P	Direct
Common Shares	Acquisiton	2017-03-07	1,100	$6.68	240,542	No	4	P	Direct
Common Shares	Acquisiton	2017-03-08	16,730	$6.82	257,272	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 6.81 to 6.95, inclusive. The reporting person undertakes to provide to GenVec, Inc, any security holder of GenVec, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.73 to $6.76, inclusive. The reporting person undertakes to provide to GenVec, Inc, any security holder of GenVec, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $6.70, inclusive. The reporting person undertakes to provide to GenVec, Inc, any security holder of GenVec, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.69 to $6.90, inclusive. The reporting person undertakes to provide to GenVec, Inc, any security holder of GenVec, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.